Emai

laddr
ess
:mohamed.
151
89@hu.
edu.
eg
Li n:ht
nkedI tps
://
www.
l
inkedi
n.com/
in/
mohamed-
khal
i
l-56057b201
Addr
ess
:Cai
ro,
Egypt
.

WORKEXPERI
ENCE

I
npat
ientphar
maci
st
ElkhankaSpeci
ali
stHos
pit
al[
01/
02/
2023_cur
rent
]

Ci
ty:Cai
ro

o Revi
ewt
hepr
escr
ibeddr
ugor
derandpat
ientmedi
cat
ionsheetf
orappr
opr
iat
eness.

o Val
idat
efort
hemedi
cat
ionpr
epar
edbef
oredi
spensi
ngt
othei
npat
ientcar
euni
ts

o Provi
detheadvi
ceandinformati
onrel
atedt
othemedi
cat
iont
oimpr
ovepr
escr
ibi
ngt
oal
lheal
thcar
e
st
affandespeci
all
ydoct
ors,nur
ses.

o Pr
omot
eadher
encet
oHeal
thandSaf
etypol
ici
es.

o Co-operat
ewi t
htheorgani
sati
oninensur
ingt
hatst
atutor
yregul
ati
ons,codesofpr
act
iceandot
her
appli
cableheal
thandsaf
etyrul
esar
eadheredt
obyal
lstaff
.

Hos
pit
alPhar
maci
st
Baheyaf
oundat
ionf
orear
lydet
ect
ionandt
reat
mentofbr
eas
tcancer[01
/06/
2021–Cur
rent]
Address
:4,All
oubaSt
.of
fEl
Har
am St
.Nextt
oDar
y,Gi
za-Egypt-ht
tps
://
baheya.
org/
en
Ci
ty:Cai
ro
Countr
y:Egypt

◦Prepareandfil
lpati
entpr escri
pti
onsandI ns
tructpati
entsonhowtousemedi
cati
ons.
◦Coll
aboratewithhealthcareteam s uchasPhys ici
ansandNur s
est
orecei
vepr
escr
ipt
ions
.
◦Ensurethatdif
fer
enttreatment sar ecompat i
ble.
◦Advisepati
entsofanyadver seside-ef
fectsofmedi ci
nes.
◦Calcul
atesdrugdosef orpat i
entsaccor di
nghisBSA.
◦I
vmi xi
ngandchemot herapypr epar at
ion(CI
VAS)phar macis
t.

Communi
typhar
maci
st
Saws
anEzzatPhar
macy[04/
09/
2020–30/
05/
2021
]
Ci
ty:Cai
ro
Countr
y:Egypt

◦Drugdis
pensi
ng.
◦Ensur
ethatdi
ffer
entt
reat
mentsarecompati
ble.
◦Advis
epati
entsofanyadver
sesi
de-ef
fect
sofmedici
nes
.cus
tomer
ssat
isf
act
ion.
EDUCATI
ON

Bachel
orofPhar
macyandDr
ugTechnol
ogy
Hel
i
opol
i
sUni
ver
sit
y[1
5/09/
201
5–1
5/07/
2020]ht
tps
://
www.
hu.
edu.
eg/

Fi
nal
grade:cGPA:3.
34outof4.
00wi
th86per
cent
ageandVer
yGoodGr
ade.

St
udiedPhar
macology,Cli
nical
Pharmacy,Biochemi
str
yandMolecularBi
ology,
Medi
ci
nal
Chemi
str
y,
DrugDesi
gn,Bi
otechnol
ogy, Mi
crobi
ology,
Pharmaceuti
csandPharmacognosy.

TRAI
NING

Nat
ionalKi
dneyI
nst
it
ute[1
4/09/
201
9–30/
09/
201
9]

◦Ensuredt heri
ghtandappr opr
iatemedicationpr escri
pti
ons.
◦Evaluatedpatient’
sconditi
ontoensureallissuesar ebei
ngt r
eated.
◦Cons ul
tedpatientfordosages
,medications ubst
anceset c.
◦Coll
abor atedwithhealt
hcareprofes
sionalstoens ureoptimalpati
entcar
e.

Res
ear
chandDevel
opmentI
nter
n
Mas
hPr
imerPhar
maceut
ical
scompany[1
0/09/
201
8–25/
09/
201
8]

◦Creat
edpolici
esandproceduresforqual
i
t yass
uranceandpr
ojectmanagement.
◦Generateddetai
ledr
eportscover
inganalysi
sofkeydata.
◦I
denti
fiedprobl
emsandr ecommendednewpr oces
sestoi
mproveit
seff
ici
ency.

LANGUAGESKI
LLS
Mot
hert
ongue(
s):
Ar
abi
c
Ot
herl
anguage(
s):
Ger
man
Engl
i
sh
LI
STENI
NGA2READI
NGA2WRI
TINGA2
LI
STENI
NGC1READI
NGC1WRI
TINGC1
SPOKENPRODUCTI
ONA2SPOKENI
NTERACTI
ONA2
SPOKENPRODUCTI
ONC1SPOKENI
NTERACTI
ONC1
VOLUNTEERI
NG

Bl
oodDonati
onCampai
gn
[Cai
ro,
201
8]

Epil
epsyAwarenes
sCampai gn
[10thofRamadancit
y,201
7]

COMMUNI
CATI
ONSKI
LLS
◦Li
st ening.
◦Conf i
dence.
◦Straightt alking.
◦Stressmanagement .
◦Emot ioncont rol.
◦Team- wor king.
◦Punct uality.
◦Criti
cal t
hi nking.
◦Creat i
vity.
◦Adapt abi l
ity.
◦Fri
endl yper sonali
ty.
◦Highlymot i
vat ed.